Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-κB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells

Jin Hee Kim, Dong Hyun Kim, Seung Hwa Baek, Ho Jae Lee, Mee Ree Kim, Ho Jeong Kwon, Choong Hwan Lee

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Nitric oxide (NO) is recognized as a mediator and regulator of inflammatory responses. Rengyolone, a cyclohexylethanoid isolated from the fruits of Forsythia koreana, exhibits anti-inflammatory activity with unknown mechanism. In this study, we found that rengyolone has a strong inhibitory effect on the production of nitric oxide (NO) and tumor necrosis factor-α (TNF-α). Rengyolone also inhibited inducible nitric oxide synthase (iNOS) gene expression and cyclooxygenase 2 (COX-2) by lipopolysaccharide (LPS). In order to explore the mechanism responsible for the inhibition of iNOS gene expression by rengyolone, we investigated its effect on LPS-induced nuclear factor-κB (NF-κB) activation. The LPS-induced DNA binding activity of NF-κB was significantly inhibited by rengyolone, and this effect was mediated through inhibition of the degradation of inhibitory factor-κBα and phosphorylation of p38 MAP kinase. Furthermore, rengyolone suppressed the expression of ICE protein in IL-1β-treated D10S cells. Taken together, these results suggest that rengyolone attenuates the inflammation through inhibition of NO production and iNOS expression by blockade of NF-κB and p38 MAPK activation in LPS-stimulated RAW 264.7 cells.

Original languageEnglish
Pages (from-to)1198-1205
Number of pages8
JournalBiochemical Pharmacology
Volume71
Issue number8
DOIs
Publication statusPublished - 2006 Apr 14

Fingerprint

p38 Mitogen-Activated Protein Kinases
Nitric Oxide Synthase Type II
Lipopolysaccharides
Nitric Oxide
Down-Regulation
Gene expression
Forsythia
Chemical activation
Gene Expression
Phosphorylation
Cyclooxygenase 2
Fruits
RAW 264.7 Cells
Rengyolone
Interleukin-1
Fruit
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Inflammation
Degradation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Pharmacology

Cite this

@article{3b83f8e8c5784ca5b8cfdc558aace768,
title = "Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-κB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells",
abstract = "Nitric oxide (NO) is recognized as a mediator and regulator of inflammatory responses. Rengyolone, a cyclohexylethanoid isolated from the fruits of Forsythia koreana, exhibits anti-inflammatory activity with unknown mechanism. In this study, we found that rengyolone has a strong inhibitory effect on the production of nitric oxide (NO) and tumor necrosis factor-α (TNF-α). Rengyolone also inhibited inducible nitric oxide synthase (iNOS) gene expression and cyclooxygenase 2 (COX-2) by lipopolysaccharide (LPS). In order to explore the mechanism responsible for the inhibition of iNOS gene expression by rengyolone, we investigated its effect on LPS-induced nuclear factor-κB (NF-κB) activation. The LPS-induced DNA binding activity of NF-κB was significantly inhibited by rengyolone, and this effect was mediated through inhibition of the degradation of inhibitory factor-κBα and phosphorylation of p38 MAP kinase. Furthermore, rengyolone suppressed the expression of ICE protein in IL-1β-treated D10S cells. Taken together, these results suggest that rengyolone attenuates the inflammation through inhibition of NO production and iNOS expression by blockade of NF-κB and p38 MAPK activation in LPS-stimulated RAW 264.7 cells.",
author = "Kim, {Jin Hee} and Kim, {Dong Hyun} and Baek, {Seung Hwa} and Lee, {Ho Jae} and Kim, {Mee Ree} and Kwon, {Ho Jeong} and Lee, {Choong Hwan}",
year = "2006",
month = "4",
day = "14",
doi = "10.1016/j.bcp.2005.12.031",
language = "English",
volume = "71",
pages = "1198--1205",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "8",

}

Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-κB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. / Kim, Jin Hee; Kim, Dong Hyun; Baek, Seung Hwa; Lee, Ho Jae; Kim, Mee Ree; Kwon, Ho Jeong; Lee, Choong Hwan.

In: Biochemical Pharmacology, Vol. 71, No. 8, 14.04.2006, p. 1198-1205.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-κB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells

AU - Kim, Jin Hee

AU - Kim, Dong Hyun

AU - Baek, Seung Hwa

AU - Lee, Ho Jae

AU - Kim, Mee Ree

AU - Kwon, Ho Jeong

AU - Lee, Choong Hwan

PY - 2006/4/14

Y1 - 2006/4/14

N2 - Nitric oxide (NO) is recognized as a mediator and regulator of inflammatory responses. Rengyolone, a cyclohexylethanoid isolated from the fruits of Forsythia koreana, exhibits anti-inflammatory activity with unknown mechanism. In this study, we found that rengyolone has a strong inhibitory effect on the production of nitric oxide (NO) and tumor necrosis factor-α (TNF-α). Rengyolone also inhibited inducible nitric oxide synthase (iNOS) gene expression and cyclooxygenase 2 (COX-2) by lipopolysaccharide (LPS). In order to explore the mechanism responsible for the inhibition of iNOS gene expression by rengyolone, we investigated its effect on LPS-induced nuclear factor-κB (NF-κB) activation. The LPS-induced DNA binding activity of NF-κB was significantly inhibited by rengyolone, and this effect was mediated through inhibition of the degradation of inhibitory factor-κBα and phosphorylation of p38 MAP kinase. Furthermore, rengyolone suppressed the expression of ICE protein in IL-1β-treated D10S cells. Taken together, these results suggest that rengyolone attenuates the inflammation through inhibition of NO production and iNOS expression by blockade of NF-κB and p38 MAPK activation in LPS-stimulated RAW 264.7 cells.

AB - Nitric oxide (NO) is recognized as a mediator and regulator of inflammatory responses. Rengyolone, a cyclohexylethanoid isolated from the fruits of Forsythia koreana, exhibits anti-inflammatory activity with unknown mechanism. In this study, we found that rengyolone has a strong inhibitory effect on the production of nitric oxide (NO) and tumor necrosis factor-α (TNF-α). Rengyolone also inhibited inducible nitric oxide synthase (iNOS) gene expression and cyclooxygenase 2 (COX-2) by lipopolysaccharide (LPS). In order to explore the mechanism responsible for the inhibition of iNOS gene expression by rengyolone, we investigated its effect on LPS-induced nuclear factor-κB (NF-κB) activation. The LPS-induced DNA binding activity of NF-κB was significantly inhibited by rengyolone, and this effect was mediated through inhibition of the degradation of inhibitory factor-κBα and phosphorylation of p38 MAP kinase. Furthermore, rengyolone suppressed the expression of ICE protein in IL-1β-treated D10S cells. Taken together, these results suggest that rengyolone attenuates the inflammation through inhibition of NO production and iNOS expression by blockade of NF-κB and p38 MAPK activation in LPS-stimulated RAW 264.7 cells.

UR - http://www.scopus.com/inward/record.url?scp=33644820971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644820971&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2005.12.031

DO - 10.1016/j.bcp.2005.12.031

M3 - Article

VL - 71

SP - 1198

EP - 1205

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -